I

Ilex Medical Ltd
TASE:ILX

Watchlist Manager
Ilex Medical Ltd
TASE:ILX
Watchlist
Price: 6 470 ILS 0.26% Market Closed
Market Cap: ₪723m

Operating Margin

6.6%
Current
Declining
by 3%
vs 3-y average of 9.6%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
6.6%
=
Operating Income
₪59.5m
/
Revenue
₪906.6m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
6.6%
=
Operating Income
₪59.5m
/
Revenue
₪906.6m

Peer Comparison

Country Company Market Cap Operating
Margin
IL
Ilex Medical Ltd
TASE:ILX
723m ILS
Loading...
US
Mckesson Corp
NYSE:MCK
100.9B USD
Loading...
US
Amerisourcebergen Corp
LSE:0HF3
68.4B USD
Loading...
US
Cencora Inc
NYSE:COR
67.8B USD
Loading...
US
Cardinal Health Inc
NYSE:CAH
49.6B USD
Loading...
AU
Sigma Healthcare Ltd
ASX:SIG
35.2B AUD
Loading...
CN
Huadong Medicine Co Ltd
SZSE:000963
66.1B CNY
Loading...
US
Henry Schein Inc
NASDAQ:HSIC
9.2B USD
Loading...
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
64.8B CNY
Loading...
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW
Loading...
CN
Sinopharm Group Co Ltd
HKEX:1099
64.9B HKD
Loading...

Market Distribution

In line with most companies in Israel
Percentile
58th
Based on 734 companies
58th percentile
6.6%
Low
-84 760% — -5.8%
Typical Range
-5.8% — 10.9%
High
10.9% — 23 869.1%
Distribution Statistics
Israel
Min -84 760%
30th Percentile -5.8%
Median 4%
70th Percentile 10.9%
Max 23 869.1%

Ilex Medical Ltd
Glance View

Market Cap
723m ILS
Industry
Health Care

Ilex Medical Ltd. engages in medical diagnostics field. The company is a supplier of in vitro diagnostic equipment and laboratory management software. The firm offers cutting-edge diagnostic equipment and reagent systems; nucleic acid testing (NAT) blood screening solutions; products for cancer screening, retro virus load, TB, and STDs, and other infectious diseases; laboratory information systems (LIS); and blood sugar monitoring products. Among the Company’s subsidiaries and affiliates are Ilex South Africa, Orsyx-LIS, Ilex BioTech Ltd and Medtechnica Ltd.

ILX Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
6.6%
=
Operating Income
₪59.5m
/
Revenue
₪906.6m
What is Ilex Medical Ltd's current Operating Margin?

The current Operating Margin for Ilex Medical Ltd is 6.6%, which is below its 3-year median of 9.6%.

How has Operating Margin changed over time?

Over the last 3 years, Ilex Medical Ltd’s Operating Margin has decreased from 17.4% to 6.6%. During this period, it reached a low of 6.6% on Oct 30, 2025 and a high of 17.4% on Sep 30, 2022.

Back to Top